Bone marrow is best known for its role in producing blood cells, but it also contains a mixture of cells and signaling components that are used in some areas of regenerative and musculoskeletal medicine. Bone marrow aspirate concentrate, commonly called BMAC, is prepared from a patient’s own bone marrow and may be considered as an orthobiologic treatment for selected musculoskeletal conditions
BMAC is sometimes discussed alongside “stem cell” treatments, but those terms should not be treated as interchangeable. BMAC is a specific preparation made from bone marrow aspirate. Understanding what it is, how it is collected and prepared, and what its limitations are can help patients have a more informed discussion about regenerative treatment options.
What Is BMAC?
BMAC stands for bone marrow aspirate concentrate. It is an autologous orthobiologic preparation, meaning the material used for the treatment comes from the patient’s own body. A physician collects a small amount of bone marrow aspirate, commonly from the pelvic bone, and the aspirate is then processed to produce a more concentrated preparation.
Bone marrow aspirate contains a mixture of cells and naturally occurring signaling components. The concentration process is intended to create a preparation that can be used in a targeted musculoskeletal procedure when clinically appropriate. BMAC is an autologous, point-of-care preparation that is minimally manipulated. It is not culture-expanded or an isolated single-cell product, and it should not automatically be described as a general form of “stem cell therapy.”
How Is Bone Marrow Aspirate Collected?
The process begins with bone marrow aspiration. After the collection area is prepared and appropriate anesthesia is used, a needle is positioned into the bone so a small amount of marrow can be withdrawn. The pelvic bone is a commonly used collection site.
The aspirated material is then processed to concentrate selected components of the marrow. The exact preparation and procedure can vary according to the clinical setting and treatment plan. Once prepared, BMAC may be delivered to a targeted musculoskeletal area using an injection technique selected for the condition being treated.
What Does BMAC Contain?
Bone marrow is a complex tissue. Aspirated marrow contains blood-forming cells, platelets, signaling molecules, and other cellular components. It can also contain a relatively small population of cells with regenerative or progenitor characteristics.
This is one reason accurate terminology matters. BMAC should not be presented as if it consists entirely of purified or isolated stem cells. It is a minimally manipulated, concentrated bone-marrow-derived preparation containing a mixture of components, produced at the point of care rather than culture-expanded in a laboratory. The composition can also vary from patient to patient and according to how the aspirate is collected and processed.
How Is BMAC Different From Stem Cell Therapy?
The phrase “stem cell therapy” is broad and can refer to very different areas of medicine and research. Stem cells may be classified according to their origin and biological capabilities, including embryonic stem cells, tissue-specific adult stem cells, and induced pluripotent stem cells used in research.
BMAC is more specific. It is prepared from the patient’s own bone marrow aspirate and contains a mixed population of cells and signaling components. It is not the same as embryonic stem-cell treatment, laboratory-generated induced pluripotent stem cells, donor-derived cell products, or treatments prepared from adipose tissue.
For a practice offering autologous BMAC, describing the procedure specifically as BMAC helps patients understand what is actually being collected and used.
Why Is BMAC Used in Regenerative Medicine?
In musculoskeletal medicine, BMAC may be considered as part of an orthobiologic treatment approach. Orthobiologic procedures use biologically derived materials with the goal of supporting the local environment involved in healing and recovery.
The clinical goal depends on the condition and the patient. BMAC should not be described as a guaranteed method for growing new cartilage, rebuilding a joint, permanently eliminating pain, or preventing surgery. Research continues to evaluate its role for different musculoskeletal applications, and outcomes can vary considerably between patients.
What Conditions May Be Evaluated for BMAC?
BMAC is not a general treatment for every type of pain or disease. In a musculoskeletal practice, selected patients with certain joint, tendon, ligament, or sports-related problems may be evaluated to determine whether an orthobiologic procedure could have a role in their treatment plan.
For example, patients with selected knee or hip conditions may discuss BMAC after the underlying cause of their symptoms has been evaluated. The presence of pain alone does not establish candidacy. Diagnosis, severity, examination findings, imaging when appropriate, previous treatment, medical history, activity demands, and treatment goals all matter.
Broad claims involving neurological disease, diabetes, heart disease, kidney disease, autoimmune disorders, fibromyalgia, or other systemic conditions should not be carried over from general stem-cell research and presented as routine BMAC indications.
Who May Be a Candidate for BMAC?
A potential candidate may be someone with a diagnosed musculoskeletal condition whose symptoms continue despite appropriate conservative care, or someone who wants to understand whether a regenerative option may be reasonable before choosing the next step in treatment.
Candidacy is individualized. Dr. Raj Desai reviews the patient’s medical history, physical examination, prior treatment, medications, imaging when indicated, functional limitations, and goals. Depending on those findings, rehabilitation, PRP, BMAC, another image-guided procedure, medication management, or surgical evaluation may be more appropriate.
What Is the Difference Between BMAC and PRP?
BMAC and platelet-rich plasma, or PRP, are both autologous orthobiologic treatments, but they are prepared from different sources. PRP is prepared from the patient’s blood and concentrates platelets and associated signaling factors. BMAC is prepared from bone marrow aspirate and contains a different mixture of cellular and signaling components.
One is not automatically better than the other. The decision to consider PRP, BMAC, or another treatment depends on the diagnosis, treatment goals, prior care, and the physician’s assessment of the individual condition.
What Does Recovery After BMAC Involve?
Recovery depends on the area treated, underlying diagnosis, procedure performed, and the patient’s usual activity level. Temporary soreness may occur at the bone marrow aspiration site and at the injection site.
Patients may need to modify activity for a period of time, and rehabilitation or physical therapy may be incorporated into the treatment plan when appropriate. Return to exercise, sports, or higher-load activity should follow individualized medical guidance rather than a universal timeline.
What Are the Limitations of BMAC?
BMAC is not appropriate for every patient and does not produce the same response in every condition. The available evidence differs by diagnosis, and research continues to examine how BMAC may be used in musculoskeletal medicine.
As with other injection-based procedures, there are also potential risks. These may include temporary pain or soreness, bruising, bleeding, infection, or irritation related to the aspiration or injection. Because the bone marrow is commonly aspirated from the posterior iliac crest, additional procedure-specific risks can include hematoma at the aspiration site and, less commonly, injury to nearby nerves. Procedure-specific risks and alternatives should be discussed during the medical evaluation.
Patients should also be cautious about claims that assign a single success percentage to BMAC or guarantee tissue regeneration, pain elimination, restored mobility, or avoidance of surgery. Expected outcomes need to be discussed in the context of the individual diagnosis.
When Should You Consider a BMAC Evaluation?
An evaluation may be appropriate when persistent musculoskeletal pain or injury is limiting activity, symptoms have continued despite appropriate conservative treatment, or you want to understand whether BMAC, PRP, or another non-surgical option may fit your condition.
The purpose of the consultation is not to assume that BMAC is the correct treatment. It is to identify the likely source of symptoms, review available options, and determine whether an orthobiologic procedure is clinically appropriate.
Patients should also be cautious about claims that assign a single success percentage to BMAC or guarantee tissue regeneration, pain elimination, restored mobility, or avoidance of surgery. Expected outcomes need to be discussed in the context of the individual diagnosis.
Talk to Dr. Raj Desai About BMAC
Dr. Raj Desai provides individualized care for chronic pain and musculoskeletal conditions using a multidisciplinary approach that may include rehabilitation, minimally invasive pain procedures, and regenerative treatment options.
If you are considering BMAC, schedule an evaluation to discuss your diagnosis, prior treatment, imaging when relevant, candidacy, expected recovery, limitations, and alternative treatment options. A personalized assessment can help determine whether BMAC has an appropriate role in your care plan.
